JP Morgan Chase’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$112K Buy
29,241
+1,207
+4% +$5.1K ﹤0.01% 5770
2025
Q4
$77.1K Sell
28,034
-408,323
-94% -$1.16M ﹤0.01% 6023
2025
Q3
$1.5M Sell
436,357
-311,710
-42% -$1.14M ﹤0.01% 4295
2025
Q2
$2.57M Buy
748,067
+405,612
+118% +$1.07M ﹤0.01% 3717
2025
Q1
$729K Buy
342,455
+193,410
+130% +$580K ﹤0.01% 4554
2024
Q4
$475K Buy
149,045
+124,133
+498% +$1.01M ﹤0.01% 5071
2024
Q3
$333K Buy
24,912
+4,844
+24% +$64.4K ﹤0.01% 5147
2024
Q2
$200K Sell
20,068
-238,045
-92% -$3.44M ﹤0.01% 5166
2024
Q1
$3.07M Buy
258,113
+258,065
+537,635% +$2.2M ﹤0.01% 3496
2023
Q4
$194 Buy
48
+15
+45% +$42 ﹤0.01% 7051
2023
Q3
$90 Buy
+33
New +$154 ﹤0.01% 6921

Other funds holding CATX